(PHILADELPHIA) – In 2002, Thomas and Carol Hallinan, of Northeast Philadelphia, lost their son, Peter, 31, to Anaplastic Oligodendroglioma – a type of brain tumor that affects 190,000 people in the U.S. each year, and is the second most common cause of cancer death in young people ages 15-34.  To honor their son’s memory, The Hallinans have partnered with the University of Pennsylvania Health System and Penn’s Department of Neurosurgery to build support for the advancement of clinical research for patients who suffer from brain tumors.  “For Pete’s Sake” – an evening of dinner, dancing, and a silent auction – is a sold-out event with an expected attendance of 250 people.  Proceeds will support brain tumor research at Penn.

WHERE:

Knowlton Mansion [directions]
8001 Verree Road
Philadelphia, PA 19111

WHEN:

March 23, 2007
6 p.m.

WHO:

M. Sean Grady, MD, Charles Harrison Frazier Professor & Chair of the Department of Neurosurgery at the University of Pennsylvania School of Medicine, will speak about current brain tumor research.

###

PENN Medicine is a $2.9 billion enterprise dedicated to the related missions of medical education, biomedical research, and high-quality patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.

Penn's School of Medicine is ranked #2 in the nation for receipt of NIH research funds; and ranked #3 in the nation in U.S. News & World Report's most recent ranking of top research-oriented medical schools. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.

The University of Pennsylvania Health System includes three hospitals, all of which have received numerous national patient-care honors [Hospital of the University of Pennsylvania; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center]; a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home care and hospice.

Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.

The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.

The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.

Share This Page: